Passa al contenuto
Merck
Tutte le immagini(1)

Documenti fondamentali

Visualizza tutta la documentazione

F0040010

Fenbendazole impurity A

European Pharmacopoeia (EP) Reference Standard

Sinonimo/i:

Carbendazim, BCM, Methyl 2-benzimidazolecarbamate, Methyl benzimidazol-2-ylcarbamate

Autenticatiper visualizzare i prezzi riservati alla tua organizzazione & contrattuali
Tutte le immagini(1)

About This Item

Formula empirica (notazione di Hill):
C9H9N3O2
Numero CAS:
10605-21-7
Peso molecolare:
191.19
Beilstein:
649044
Numero MDL:
MFCD00055390
Codice UNSPSC:
41116107
ID PubChem:
329799622
NACRES:
NA.24
Prezzi e disponibilità al momento non sono disponibili

Grado

pharmaceutical primary standard

Famiglia di API

fenbendazole

Produttore/marchio commerciale

EDQM

Punto di fusione

>300 °C (lit.)

applicazioni

pharmaceutical (small molecule)

Formato

neat

Temperatura di conservazione

2-8°C

Stringa SMILE

COC(=O)Nc1nc2ccccc2[nH]1

InChI

1S/C9H9N3O2/c1-14-9(13)12-8-10-6-4-2-3-5-7(6)11-8/h2-5H,1H3,(H2,10,11,12,13)
TWFZGCMQGLPBSX-UHFFFAOYSA-N

Cerchi prodotti simili? Visita Guida al confronto tra prodotti

Descrizione generale

This product is provided as delivered and specified by the issuing Pharmacopoeia. All information provided in support of this product, including SDS and any product information leaflets have been developed and issued under the Authority of the issuing Pharmacopoeia.For further information and support please go to the website of the issuing Pharmacopoeia.

Applicazioni

Fenbendazole impurity A EP Reference standard, intended for use in laboratory tests only as specifically prescribed in the European Pharmacopoeia.

Confezionamento

The product is delivered as supplied by the issuing Pharmacopoeia. For the current unit quantity, please visit the EDQM reference substance catalogue.

Altre note

Sales restrictions may apply.

Prodotti correlati

N° Catalogo
Descrizione
Determinazione del prezzo

1269403

Fenbendazole, United States Pharmacopeia (USP) Reference Standard

F0040000

Fenbendazole, European Pharmacopoeia (EP) Reference Standard

F0040020

Fenbendazole impurity B, European Pharmacopoeia (EP) Reference Standard

1269414

Fenbendazole Related Compound A, United States Pharmacopeia (USP) Reference Standard

1269425

Fenbendazole Related Compound B, United States Pharmacopeia (USP) Reference Standard

PHR1832

Fenbendazole, Pharmaceutical Secondary Standard; Certified Reference Material

BP692

Fenbendazole, British Pharmacopoeia (BP) Reference Standard

PHR2863

Fenbendazole Related Compound B, certified reference material, pharmaceutical secondary standard

Avvertenze

Danger

Indicazioni di pericolo

H317,H340,H360FD,H410

Classi di pericolo

Aquatic Acute 1 - Aquatic Chronic 1 - Muta. 1B - Repr. 1B - Skin Sens. 1

Codice della classe di stoccaggio

6.1C - Combustible acute toxic Cat.3 / toxic compounds or compounds which causing chronic effects

Classe di pericolosità dell'acqua (WGK)

WGK 3

Punto d’infiammabilità (°F)

Not applicable

Punto d’infiammabilità (°C)

Not applicable

Scegli una delle versioni più recenti:

Certificati d'analisi (COA)

Lot/Batch Number

It looks like we've run into a problem, but you can still download Certificates of Analysis from our Documenti section.

Se ti serve aiuto, non esitare a contattarci Servizio Clienti

Possiedi già questo prodotto?

I documenti relativi ai prodotti acquistati recentemente sono disponibili nell’Archivio dei documenti.

Visita l’Archivio dei documenti

I clienti hanno visto anche

Slide 1 of 1

1 of 1

Carbendazim PESTANAL®, analytical standard

Supelco

45368

Carbendazim

Jae-Ran Lee et al.
Human mutation, 36(1), 69-78 (2014-09-30)
KIF1A is a neuron-specific motor protein that plays important roles in cargo transport along neurites. Recessive mutations in KIF1A were previously described in families with spastic paraparesis or sensory and autonomic neuropathy type-2. Here, we report 11 heterozygous de novo
Wojciech Dabrowski et al.
Clinical nephrology, 82(1), 41-50 (2014-06-03)
To analyze the effect and the time course of continuous veno-venous hemofiltration (CVVH) with net ultrafiltration (UF) on intra-abdominal pressure (IAP) body fluid volumes in septic shock patients with acute kidney injury (AKI). Patients were studied at baseline and after
D K Bayer et al.
Clinical and experimental immunology, 178(3), 459-469 (2014-07-22)
In areas without newborn screening for severe combined immunodeficiency (SCID), disease-defining infections may lead to diagnosis, and in some cases, may not be identified prior to the first year of life. We describe a female infant who presented with disseminated
Petra Hegerová et al.
Nutrition (Burbank, Los Angeles County, Calif.), 31(1), 166-170 (2014-12-04)
An acute disease is regularly associated with inflammation, decreased food intake, and low physical activity; the consequence is loss of muscle mass. However, the restoration of muscle tissue is problematic, especially in older patients. Loss of muscle mass leads to
Ismail Kocyigit et al.
Peritoneal dialysis international : journal of the International Society for Peritoneal Dialysis, 34(7), 781-790 (2014-01-05)
In this study our aim was to evaluate the relationship between degree of fluid status and arterial stiffness measured by pulse wave velocity (PWV) in peritoneal dialysis (PD) patients. Fluid status was determined by different methods including fluid overload measured
Visualizza tutti i documenti correlati

Questions

Reviews

No rating value

Active Filters

Il team dei nostri ricercatori vanta grande esperienza in tutte le aree della ricerca quali Life Science, scienza dei materiali, sintesi chimica, cromatografia, discipline analitiche, ecc..

Contatta l'Assistenza Tecnica.